Literature DB >> 21248772

Loss of E2F7 expression is an early event in squamous differentiation and causes derepression of the key differentiation activator Sp1.

Mehlika Hazar-Rethinam1, Sarina R Cameron, Alison L Dahler, Liliana B Endo-Munoz, Louise Smith, Danny Rickwood, Nicholas A Saunders.   

Abstract

Squamous differentiation is controlled by key transcription factors such as Sp1 and E2F. We have previously shown that E2F1 can suppress transcription of the differentiation-specific gene, transglutaminase type 1 (TG1), by an indirect mechanism mediated by Sp1. Transient transfection of E2F1-E2F6 indicated that E2F-mediated reduction of Sp1 transcription was not responsible for E2F-mediated suppression of squamous differentiation. However, we found that E2F4 and E2F7, but not E2Fs 1, 2, 3, 5, or 6, could suppress the activation of the Sp1 promoter in differentiated keratinocytes (KCs). E2F4-mediated suppression could not be antagonized by E2Fs 1, 2, 3, 5, or 6 and was localized to a region of the human Sp1 promoter spanning -139 to + 35 bp. Chromatin immunoprecipitation analysis, as well as transient overexpression and short hairpin RNA knockdown experiments indicate that E2F7 binds to a unique binding site located between -139 and -119 bp of the Sp1 promoter, and knockdown of E2F7 in proliferating KCs leads to a derepression of Sp1 expression and the induction of TG1. In contrast, E2F4 knockdown in proliferating KCs did not alter Sp1 expression. These data indicate that loss of E2F7 during the initiation of differentiation leads to the derepression of Sp1 and subsequent transcription of differentiation-specific genes such as TG1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21248772     DOI: 10.1038/jid.2010.430

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression.

Authors:  Luis A Carvajal; Pierre-Jacques Hamard; Crystal Tonnessen; James J Manfredi
Journal:  Genes Dev       Date:  2012-07-15       Impact factor: 11.361

2.  Differential Expression of Proteins in an Atypical Presentation of Autoimmune Lymphoproliferative Syndrome.

Authors:  Dulce María Delgadillo; Adriana Ivonne Céspedes-Cruz; Emmanuel Ríos-Castro; María Guadalupe Rodríguez Maldonado; Mariel López-Nogueda; Miguel Márquez-Gutiérrez; Rocío Villalobos-Manzo; Lorena Ramírez-Reyes; Misael Domínguez-Fuentes; José Tapia-Ramírez
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

Review 3.  The role of the E2F transcription factor family in UV-induced apoptosis.

Authors:  Mehlika Hazar-Rethinam; Liliana Endo-Munoz; Orla Gannon; Nicholas Saunders
Journal:  Int J Mol Sci       Date:  2011-12-06       Impact factor: 5.923

4.  CtBP2 proteome: Role of CtBP in E2F7-mediated repression and cell proliferation.

Authors:  Ling-Jun Zhao; T Subramanian; S Vijayalingam; G Chinnadurai
Journal:  Genes Cancer       Date:  2014-04

5.  An E2F7-dependent transcriptional program modulates DNA damage repair and genomic stability.

Authors:  Jone Mitxelena; Aintzane Apraiz; Jon Vallejo-Rodríguez; Iraia García-Santisteban; Asier Fullaondo; Mónica Alvarez-Fernández; Marcos Malumbres; Ana M Zubiaga
Journal:  Nucleic Acids Res       Date:  2018-05-18       Impact factor: 16.971

6.  The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells.

Authors:  B Salvatori; I Iosue; A Mangiavacchi; G Loddo; F Padula; S Chiaretti; N Peragine; I Bozzoni; F Fazi; A Fatica
Journal:  Cell Death Dis       Date:  2012-10-25       Impact factor: 8.469

7.  Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer.

Authors:  I Thurlings; L M Martínez-López; B Westendorp; M Zijp; R Kuiper; P Tooten; L N Kent; G Leone; H J Vos; B Burgering; A de Bruin
Journal:  Oncogene       Date:  2016-07-25       Impact factor: 9.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.